HD-OPM Archive
Topics › Brain health & dementia

Bredesen comments on Ted Turner's Lewy body dementia and promotes his ReCODE protocol

Louis Nervegna · May 07, 2026 · ♥ 7 reactions · 0 comments · original Facebook post
Brain health & dementia
AI summary & key facts

Shared commentary from Dale Bredesen after Ted Turner's death, promoting his ReCODE precision-medicine protocol and calling for a clinical trial in Lewy body dementia. No new evidence is presented.

#lewybodydementiaHD #bredesenHD #tedturnerHD

As you may have read, Ted Turner, founder of CNN, has just passed away after years with Lewy body dementia. There are approximately one million Americans with Lewy body dementia, and ongoing research has revealed many parallels to Alzheimer’s, such as the central roles of energetics, inflammation, and toxicity (and toxicity is particularly important to evaluate and address in Lewy body dementia).

Just as for Alzheimer’s, Lewy body dementia should be much less common, and if everyone would undergo appropriate, thorough testing and treatment early in the course, it would be. We have seen success with the precision medicine protocol we use (ReCODE), and we now need a clinical trial, just as the one we have recently completed for Alzheimer’s.

Let’s all work together to reduce the global burden of Alzheimer’s, Lewy body disease, and all forms of dementia—for any of us with any symptoms of cognitive decline, we should not delay evaluation and treatment. I hope that part of Ted Turner’s legacy will be to have CNN one day report the significant reduction in dementia that we now know is possible.

← newer: LDL and hearing loss are top modifiable dementia risk factorolder: Lewy body dementia is the second most common dementia, on a →